CONTINUE TO SITE >
OR WAIT 15 SECS
Search
Spotlight
Autoimmune Diseases
Cardiovascular Diseases
Eyecare
How to Reduce Maternal, Infant Health Risks During COVID-19
Multiple Sclerosis
Secondary Progressive Multiple Sclerosis: Patient Impact and Coverage Implications for New Therapies
The Improving Patient Access Podcast
Business
Business Strategy
Consumers
Drug Costs
Drug Pipeline
Formulary
Health Management
Health/Disease Strategy
Hospitals & Providers
Industry Analysis
Pharmacy
Politics and Policy
Practice Management
Reimbursement
Technology
Clinical
Autoimmune Diseases
Biosimilars
Dermatology
Diabetes
Eyecare
HIV
Leukemia and Lymphoma
Mental Health
Obstetrics-Gynecology & Women's Health
Oncology
Opioids
Pediatrics
Plaque Psoriasis
Solid Tumors
Urology
News
Media
Expert Interviews
K-Cast
Medical World News
Podcasts
Population Health Perspectives
Conferences
Publications
MHE Publication
Resources
Education
Sponsored Resources
Surveys
Subscribe
eNewsletter
Print Subscription
Search
Spotlight
Autoimmune Diseases
Cardiovascular Diseases
Eyecare
How to Reduce Maternal, Infant Health Risks During COVID-19
Multiple Sclerosis
Secondary Progressive Multiple Sclerosis: Patient Impact and Coverage Implications for New Therapies
The Improving Patient Access Podcast
Business
See All >
Business Strategy
Consumers
Drug Costs
Drug Pipeline
Formulary
Health Management
Health/Disease Strategy
Hospitals & Providers
Industry Analysis
Pharmacy
Politics and Policy
Practice Management
Reimbursement
Technology
Clinical
See All >
Autoimmune Diseases
Biosimilars
Dermatology
Diabetes
Eyecare
HIV
Leukemia and Lymphoma
Mental Health
Obstetrics-Gynecology & Women's Health
Oncology
Opioids
Pediatrics
Plaque Psoriasis
Solid Tumors
Urology
January 2004 FDA Pipeline
January 1, 2004
New molecular entities, new biologics and new formulations
Related Article >>>
